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Abstract
Background and Aims: Both deoxynivalenol (DON) and nontyphoidal salmonellosis are emerging threats with possible
hazardous effects on both human and animal health. The objective of this study was to examine whether DON at low but
relevant concentrations interacts with the intestinal inflammation induced by Salmonella Typhimurium.
Methodology: By using a porcine intestinal ileal loop model, we investigated whether intake of low concentrations of DON
interacts with the early intestinal inflammatory response induced by Salmonella Typhimurium.
Results: A significant higher expression of IL-12 and TNFa and a clear potentiation of the expression of IL-1b, IL-8, MCP-1
and IL-6 was seen in loops co-exposed to 1 mg/mL of DON and Salmonella Typhimurium compared to loops exposed to
Salmonella Typhimurium alone. This potentiation coincided with a significantly enhanced Salmonella invasion in and
translocation over the intestinal epithelial IPEC-J2 cells, exposed to non-cytotoxic concentrations of DON for 24 h. Exposure
of Salmonella Typhimurium to 0.250 mg/mL of DON affected the bacterial gene expression level of a limited number of
genes, however none of these expression changes seemed to give an explanation for the increased invasion and
translocation of Salmonella Typhimurium and the potentiated inflammatory response in combination with DON.
Conclusion: These data imply that the intake of low and relevant concentrations of DON renders the intestinal epithelium
more susceptible to Salmonella Typhimurium with a subsequent potentiation of the inflammatory response in the gut.
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Introduction
The contamination of food and feed with mycotoxins poses a
worldwide problem with an acknowledged negative effect on both
human and animal health and significant economic and
international trade implications. Deoxynivalenol (DON) is a
trichothecene mycotoxin frequently contaminating maize and
small grain cereals in temperate regions of Europe, North America
and Asia [1]. The intake of DON contaminated food or feed can
lead to adverse health effects in both humans and animals. For
humans, a large-scale European study on the occurrence of
Fusarium toxins and the dietary intake showed that 57% of the
tested cereals samples such as wheat were positive for DON and
based on the intake estimates, it is clear that the presence of
trichothecenes can pose a public health concern [2,3]. A study on
the prevalence and level of urinary DON in the United Kingdom
population indicated that urinary levels of DON were positively
correlated with cereal intake suggesting that the European Union
recommended maximum tolerable daily intake of 1 mg DON/kg
BW may be exceeded. Urinary DON levels can be a valuable tool
as exposure biomarker for biomonitoring in etiological studies of
DON and human disease risks [4]. For human food products, the
European Union sets maximum limits for DON in cereals and
cereal-based products, ranging from 200 to 1750 mg/kg [5].
Anorexia, altered feed intake, reduced weight gain and immuno-
logic alterations are associated with chronic low-doses ingestion of
DON whereas acute high-dose exposure is characterized by
emesis, diarrhea, vomiting and rectal bleeding. Among farm
animals, pigs are considered particularly sensitive to the dietary
intake of DON resulting in substantial economical losses [6].
Nontyphoidal Salmonella represents an important human and
animal pathogen worldwide. Each year approximate 93.8 million
human cases of gastroenteritis occur due to Salmonella Typhimur-
ium around the world [7]. In 2009, Salmonella was the most
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commonly reported bacteriological agent of human food borne
diseases in the USA, causing approximate 44% of confirmed food
borne bacterial infections [8]. Salmonella Typhimurium is, together
with Salmonella Enteriditis, the most common serotype associated
with human nontyphoidal salmonellosis in Europe and USA
[9,10]. In pigs, clinical salmonellosis is not a common problem as
Salmonella infections are mostly subclinical. However, these carrier
pigs are an important contaminating source for the environment,
other pigs and carcasses in the slaughterhouse and as such they
pose a serious public health problem being the most important
reservoir of Salmonella Typhimurium for humans [11–13].
Several studies already described the direct effects of the intake
of DON contaminated food or feed on the gastrointestinal tract
[14–23], however only few examined the possible link between
DON ingestion and intestinal inflammation using in vitro intestinal
cells line models [24–29]. The general effects of mycotoxins on the
local intestinal immune response were reviewed by Bouhet and
Oswald [24], whereas Mbandi and Pestka [27] examined the
capacity of DON to potentiate chemokine and proinflammatory
cytokine production in murine macrophages induced by killed
irradiated suspensions of Salmonella Typhimurium, concluding that
the induction of IL-1b, IL-6, TNFa and MIP-2 by the pathogen
was potentiated by DON. Maresca et al. [26] indicated that besides
the direct pro-inflammatory effect and potentiation of an existing
inflammation, DON could also cause intestinal inflammation
indirectly through alteration of the intestinal barrier function. Van
De Walle et al. [28,29] suggested that high concentrations of DON
could trigger intestinal inflammation and worsen inflammation
related parameters.
Recently a potential link between food-associated exposure to
certain mycotoxins including DON, and the induction and/or
persistence of Inflammatory Bowel Disease (IBD) in genetically
predisposed patients has been suggested [25]. At realistic doses,
mycotoxins are able to cause immune and intestinal alterations
comparable with those involved in human chronic intestinal
inflammatory diseases [24]. In addition, infections with enteric
pathogens such as nontyphoidal Salmonella have been implicated in
the etiology of IBD [30,31].
With DON and salmonellosis being emerging issues with
possible deleterious consequences for both animal and human
health and with the gastrointestinal tract being the primary target
for both, we aimed to test whether DON at low but relevant
concentrations interacts with the intestinal inflammation induced
by Salmonella Typhimurium using a porcine model of infection,
representative of the human gastrointestinal gut [32–34].
Materials and Methods
Ethics statement
The in vivo experimental protocols and care of the animals were
approved by the Ethical Committee of the Faculty of Veterinary
Medicine, Ghent University, Belgium (EC 2010/065, May 3,
2010).
Chemicals
DON stock solution of 1 mg/mL (Sigma-Aldrich, Steinheim,
Germany) was prepared in anhydrous methanol and stored at
220uC. Serial dilutions of DON were prepared in cell medium or
Luria-Broth (LB, Sigma-Aldrich), depending on the experiment.
Bacterial strains and growth conditions
Salmonella enterica subspecies enterica serovar Typhimurium
(Salmonella Typhimurium) strain 112910a was used as wild type
strain. To obtain highly invasive late logarithmic cultures for
invasion assays, 2 mL of a stationary phase culture was inoculated
in 5 mL LB and grown for 5 h at 37uC without aeration.
The inocula for the intestinal loop model were prepared
according to the temperature shift method for Salmonella. Cultures
in LB were shaken at 130 rpm for 24 h at 25uC. After diluting
threefold and adjusting the OD600 nm to 1, the bacteria were
incubated for 2 h at 37uC, with shaking at 130 rpm. The actual
number of bacteria/ml was assessed by plating tenfold dilutions on
Brilliant Green agar (BGA, Oxoid, Hampshire, UK).
Cell cultures
The IPEC-J2 cell line, a non-transformed intestinal cell line,
which was originally derived from jejunal epithelium of an
unsuckled piglet was used for all the experiments [35,36]. IPEC-J2
cells were cultured in Dulbecco’s Modified Eagle Medium
(DMEM)/Ham’s F-12 (1:1) (InvitrogenTM Life Technologies,
Carlsbad, CA, USA) supplemented with 5% (v/v) FCS (Hyclone,
Cramlington, England, UK), 1% (v/v) insulin/transferrin/Na-
selenite (Gibco, Life Technologies, Paisley, Scotland), 1% (v/v)
penicillin/streptomycin (Gibco) and 1% (v/v) kanamycin (Gibco).
Cytotoxicity assay
IPEC-J2 cells were seeded into a 96-well plate at a
concentration of 16105 cells/mL and cultured for 1 day or 21
days, representing undifferentiated proliferating and highly
differentiated IPEC-J2 cells respectively, after which the cells were
exposed to DON at a concentration of 0.01, 0.025, 0.05, 0.1, 0.25,
0.5, 1, 5 or 10 mg/mL during 24 h. The cells were maintained in
an atmosphere of 5% CO2 at 37uC. To assess cytotoxicity, 150 mL
of freshly prepared neutral red solution (33 mg/L in DMEM
without phenol red) prewarmed to 37uC was added to each well
and the plate was incubated at 37uC for an additional 2 hours.
The cells were then washed two times with Hanks Buffered Saline
Solution (HBSS) and 150 mL of extracting solution (ethanol/Milli-
Q water/acetic acid, 50/49/1 (v/v/v)) was added in each well.
The plate was shaken for 10 min. The absorbance was determined
at 540 nm using a microplate ELISA reader (Multiscan MS,
Thermo Labsystems, Helsinki, Finland). The percentage of viable
cells was calculated using the following formula:
% viability~100|
a{bð Þ
c{bð Þ
In this formula a=OD540 nm derived from the wells incubated
with DON, b=OD540 nm derived from blank wells, c =OD540 nm
derived from untreated control wells.
Invasion and translocation assays of Salmonella
Typhimurium in porcine intestinal epithelial cells
To examine whether the ability of Salmonella Typhimurium to
invade in and pass over a monolayer of IPEC-J2 cells was altered
after pre-exposure of the IPEC-J2 cells to DON, invasion and
translocation assays were performed.
For the invasion assays, IPEC-J2 cells were seeded in 24-well
plates at a density of 16105 cells per well and were cultured for 1
day or 21 days depending on the experimental setup. . The 1-day-
old cells were then exposed either to non-cytotoxic concentrations
of DON up to 0.1 mg/mL, and to 0.25 mg/mL which decreased
the percentage of viable cells to 62.3% as determined by the
cytotoxicity assay described above. The 21-days-old IPEC-J2 cells
were exposed to non-cytotoxic concentrations of DON up to
1 mg/mL. The invasion assay was performed as described by
Boyen et al. [37]. To quantify the transepithelial passage of
DON Potentiates Inflammation by Salmonella
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Salmonella Typhimurium over IPEC-J2 cells exposed to DON,
IPEC-J2 cells were seeded on TranswellH inserts with a pore size of
3.0 mm and membrane diameter of 6.5 mm (Corning Costar
Corp., Cambridge, MA) at a density of 56105 cells/mL and
cultured until 21 days after reaching confluence. Cell medium was
refreshed every 3 days. DON was added at concentrations of 0.1,
0.25, 0.5, 0.75 or 1 mg/mL to the apical side in 200 mL of culture
medium. The basolateral side received 1 mL of blank culture
medium. After 24 h of treatment with DON, the TranswellH
inserts were washed three times with HBSS. Then Salmonella
Typhimurium was added to the apical compartment at a
concentration of 26107 Colony Forming Units (CFU/mL)
suspended in IPEC-J2 medium with the respective concentrations
of DON but without supplementation of antibiotics. The
basolateral compartment was filled with antibiotic-free IPEC-J2
medium. After 60 min at 37uC and 5% CO2, the number of
bacteria (CFU/mL) was determined in the basolateral compart-
ment by plating 10-fold dilutions on BGA plates. Transepithelial
electrical resistance (TEER) measurements were performed before
and after the incubation with DON in order to evaluate the cell
barrier integrity.
Porcine intestinal ileal loop experiments
Considering the fact that the gastrointestinal tract and the
immune system of pigs are very similar to that of humans [32–34],
pig intestinal loops were used to reproduce Salmonella Typhimur-
ium induced intestinal inflammation.
Two 5-week-old pigs were used in the gut loop experiments.
Feed was deprived for 16 h before surgery. The pigs were
anesthetized with a mixture of tiletamine+zolazepam (Zoletil 100,
Virbac, Carros, France) and xylazine (Xyl-M 2%, VMD,
Arendonk, Belgium), given intramuscularly at 0.2 mL/kg body-
weight after which they were intubated intratracheally. Anesthesia
was maintained with 1–3% isoflurane in conjunction with 1%
pure oxygen using a semiclosed circuit. Intramuscular injection of
fentanyl (5 mg/kg BW/h) was used for pain management. The
porcine ligated loop model was performed as described before with
slight modifications [37]. After cleaning and disinfection of the
abdomen, a ventral line laparotomy was performed aseptically and
twelve loops were produced commencing at the distal ileum, each
6 cm in length with a short intervening segment in between.
Ligation was done by an intestinal circumferential ligature through
the mesentery without damaging grossly visible mesenteric arcades
and thus maintaining full blood supply for both loops and inter-
loop segments. A volume of 1 mL of each test condition was
injected into each loop. In each pig, the treatments were randomly
assigned and performed in triplicate. Following test conditions
were included: negative control (LB), 1 mg/mL of DON in LB,
46108 CFU/mL of Salmonella Typhimurium and 1 mg/mL of
DON in combination with 46108 CFU/mL of Salmonella
Typhimurium. Piglets were maintained under anesthesia for 6 h
after which they were euthanized using T61 intravenously
(0.3 ml/kg bodyweight) (Intervet, Ukkel, Belgium) while still
anesthetized. The pieces of the ligated intestine were then quickly
excised from each loop and processed for RNA isolation.
Analysis of intestinal cytokine response
For RNA extraction pieces of tissue samples were collected from
the ileal loops, immediately frozen in liquid nitrogen and stored at
270uC until analysis. Total RNA from the intestinal samples was
isolated using RNAzolHRT (MRC Inc., Cincinnati, USA)
according to the manufacturer’s instructions. The RNA concen-
tration was measured by absorbance at 260 nm using Nanodrop
spectrophotometer (Thermo Scientific, Wilmington, USA) and the
purity of the RNA samples was checked using an Experion RNA
StdSens Analysis kit (Biorad Laboratories, Hercules, CA, USA).
Reverse transcription was carried out using the iScript cDNA
Synthesis Kit (Biorad Laboratories). Briefly, reverse transcription
was carried out in a 20 mL final volume that included 4 mL of 56
iScript Reaction Mix, 1 mL of iScript Reverse Transcriptase, 1 mL
of RNA template (1 mg), and nuclease-free water to complete the
final volume. The reverse transcription mix was incubated at 25uC
for 5 min, heated to 42uC for 30 min, and inactivated at 85uC for
5 min. The resultant cDNA was stored (220uC) until further use.
Primers used for the amplification were designed using Primer3
software (available at http://frodo.wi.mit.edu/primer3) using the
GeneBank sequences [38]. The primers for IL-8, TNFa and IL-12
were adopted from Volf et al. [39,40]. The specificity of the
primers was tested by performing a BLAST search against the
genomic NCBI database. To optimize the amplification proce-
dure, all primer pairs were designed to be used at the same
annealing temperature (60uC). The list of genes and sequences of
the primers used for quantitative PCR analysis are listed in
Table 1. HPRT and HIS were used as housekeeping genes. Both
genes had a stable expression, in all the samples tested, as
calculated using the geNorm software (data not shown).
To quantify the products of interest (IL-1b, IL-6, IL-8, IL-12,
IL-18, TNFa, IFNc and MCP-1) real-time quantitative PCR was
utilized. The PCR reaction was carried out in 96-well plates with
the appropriate forward and reverse primers (500 nM), 5 mL of
iQTM SYBRHGreen Supermix (Biorad) and 1 mL of the fivefold
diluted cDNA template. Thermocycling parameters were used
according to the manufacturer’s instructions and included 40
cycles of 20 s at 95uC, 30 s at 60uC, 30 s at 73uC. The threshold
cycle values (Ct) were first normalized to the geometric means of
appropriate reference mRNAs and the normalized mRNA levels
were calculated according to 22DDCt method [41].
Micro-array analysis of Salmonella Typhimurium gene
expression
To test whether DON affected the gene expression of Salmonella
Typhimurium, a microarray analysis was performed on RNA
isolated from cultures of Salmonella Typhimurium grown to
logarithmic and stationary phase in the presence or absence of
0.250 mg/mL of DON. This concentration was chosen based on
the results of the in vitro assays on IPEC-J2 cells.
Stationary phase cultures were obtained by aerated, overnight
culture at 37uC in 5 mL LB in 50 mL flasks. To obtain highly
invasive late logarithmic culture, 2 mL of a stationary phase culture
was inoculated in 5 mL LB and grown for 5 hours at 37uC
without aeration [42].
Of the stationary and logarithmic culture respectively, 2.00
OD600 units were harvested and RNA was extracted and purified
using SV Total RNA Isolation Kit (Promega Benelux bv, Leiden,
The Netherlands) according to manufacturers’ instructions. The
quality and purity of the isolated RNA was determined using a
Nanodrop spectrophotometer and Experion RNA StdSens
Analysis kit (Biorad). The SALSA microarrays and protocols for
RNA labeling, microarray hybridization and subsequent data
acquisition have been described previously [43]. RNA (10 mg)
from 3 independent biological replicates of DON treated and
untreated (control) logarithmic and stationary phase cultures was
labeled with Cy5 dCTP and hybridized to SALSA microarrays
with 400 ng of Cy3 dCTP labeled gDNA, as a common reference.
Genes were assessed to be statistically significantly differently
expressed between the DON treated and untreated controls at
each growth phase by an analysis of variance test with a Benjamini
DON Potentiates Inflammation by Salmonella
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and Hochberg false discovery rate of 0.05 and with a $1.5-fold
change in the expression level.
Micro array accession number
The microarray data discussed in this publication are MIAME
compliant and have been deposited in NCBI’s Gene Expression
Omnibus [44] and are accessible through GEO Series accession
number GSE29399 (http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE29399).
Statistical analysis
All in vitro experiments were conducted in triplicate with three
repeats per experiment, unless otherwise noted. The data were
analyzed using Student’s t-test to address the significance of
difference between mean values with significance set at 0.05.
The differences in mRNA expression among groups were
assessed by performing two-factor ANOVA after determination of
normality and variance homogeneity. Multiple comparisons were
performed using LSD. Not normally distributed data were
analyzed using the non parametric Kruskal-Wallis analysis,
followed by Mann-Whitney test using SPSS 17.0 Software (SPSS
Inc., Chicago, IL, USA). Significance level was set at 0.05.
Results
DON is more toxic to undifferentiated than to
differentiated IPEC-J2 cells
The cytotoxic effect of DON on IPEC-J2 cells as determined
using the neutral red assay is shown in Figure 1. The viability of
1-day-old IPEC-J2 cells was significantly decreased by exposure to
concentrations of DON higher than 0.1 mg/mL (Figure 1A).
DON concentrations up to 10 mg/mL did not significantly affect
the viability of differentiated IPEC-J2 cells (Figure 1B). However,
although not significant, exposure of differentiated IPEC-J2 cells to
5 and 10 mg/mL of DON during 24 h reduced the viability to
86+/27% and 80+/24% respectively.
DON promotes the invasion of Salmonella Typhimurium
in IPEC-J2 cells
The results of the invasion assay with Salmonella Typhimurium
in actively dividing IPEC-J2 cells grown are shown in Figure 2A
whereas Figure 2B illustrates the invasion of Salmonella Typhi-
murium in differentiated IPEC-J2 cells.
The invasion of Salmonella Typhimurium was higher in
undifferentiated proliferating IPEC-J2 cells exposed to concentra-
tions of DON higher than 0.025 mg/mL in comparison to non
Table 1. List of genes and sequences of the primers used for quantitative PCR analysis.
Gene name Forward primer (59R39) Reverse primer (39R59) Accession number
HPRT GAGCTACTGTAATGACCAGTCAACG CCAGTGTCAATTATATCTTCAACAATCAA NM_001032376
HIS AAACAGATCTGCGCTTCC GTCTTCAAAAAGGCCAAC NM_213930
IL-1b GGGACTTGAAGAGAGAAGTGG CTTTCCCTTGATCCCTAAGGT NM_001005149
IL-6 CACCGGTCTTGTGGAGTTTC GTGGTGGCTTTGTCTGGATT M86722
IL-8 TTCTGCAGCTCTCTGTGAGGC GGTGGAAAGGTGTGGAATGC M86923
IL-12 CACTCCTGCTGCTTCACAAA CGTCCGGAGTAATTCTTTGC U08317
IL-18 ATGCCTGATTCTGACTGTTC CTGCACAGAGATGGTTACTGC AB010003
TNFa CCCCCAGAAGGAAGAGTTTC CGGGCTTATCTGAGGTTTGA NM_214022
IFNc CCATTCAAAGGAGCATGGAT GAGTTCACTGATGGCTTTGC AY188090
MCP-1 CAGAAGAGTCACCAGCAGCA TCCAGGTGGCTTATGGAGTC NM_214214
doi:10.1371/journal.pone.0023871.t001
Figure 1. Percentage viability (%) of IPEC-J2 cells exposed to
different concentrations of DON (0.005–1 mg/mL). IPEC-J2 cells
were grown to a confluent monolayer during 1 day (A) or grown until
differentiation during 21 days (B). Twenty-four hours after incubation
with DON, the cytotoxic effect was determined using neutral red assay.
Results represent the means of 3 independent experiments conducted
in triplicate and their standard error of the mean. * refers to a
significantly higher cytotoxic effect compared to the unexposed control
cells (p,0.05).
doi:10.1371/journal.pone.0023871.g001
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treated IPEC-J2 cells, with a significant increased invasion when
exposed to 0.1 and 0.25 mg/mL of DON during 24 h (p,0.05),
although the latter (0.25 mg/mL) reduced the percentage of viable
IPEC-J2 cells to 62.3%The same tendency was seen in highly
differentiated 21-days-old IPEC-J2 cells, where exposure to non
cytotoxic concentrations of DON led to a dose-dependent increase
of the invasion of Salmonella Typhimurium in the cells. Exposure to
concentrations of DON$0.75 mg/mL resulted in a significantly
higher bacterial count in IPEC-J2 cells compared to non treated
control cells.
DON increases the transepithelial passage of Salmonella
Typhimurium through the intestinal epithelium
We assessed the passage of Salmonella Typhimurium through 21-
days-old IPEC-J2 cells treated for 24 h with non-cytotoxic
concentrations of DON varying from 0.1 to 1 mg/mL
(Figure 3). Exposure to DON for 24 h did not lead to a decrease
in TEER (data not shown) indicating no loss of integrity of the
epithelial monolayer. However, there was a significant increase in
the passage of Salmonella Typhimurium bacteria (p,0.05) after
exposure to 0.5, 0.75 and 1 mg/mL of DON in comparison to non
treated IPEC-J2 cells.
DON potentiates the intestinal inflammatory response to
Salmonella Typhimurium in the porcine intestinal ileal
loop model
Using the porcine intestinal loop model, the effect of 1 mg/mL
of DON, Salmonella Typhimurium and co-exposure of Salmonella
Typhimurium with 1 mg/mL of DON on the intestinal mRNA
expression levels of the cytokines (IL-1b, IL-6, IL-12, IL-18, IFNc
and TNFa) and chemokines (IL-8 and MCP-1) 6 hours post
administration was examined. The results are illustrated in
Figure 4. Exposure to 1 mg/mL of DON did not significantly
affect the mRNA expression level of any cytokine and chemokine
tested. Co-exposure of the ileal loops to 1 mg/mL of DON and
Salmonella Typhimurium for 6 hours, resulted in a potentiated
intestinal immune response in comparison to loops incubated with
Salmonella Typhimurium but without the presence of DON.
Although not significant except for TNFa and IL-12 (p,0.05),
there was a higher increase in fold change in mRNA expression
compared to the Salmonella Typhimurium inoculated loops for IL-
1b (10.9 to 6.1 respectively), IL-12 (6.5 to 2.3 respectively), IL-8
(6.2 to 3.0 respectively), MCP-1 (2.5 to 1.2 respectively), TNFa
(1.8 to 0.9 respectively) and IL-6 (1.6 to 1.1 respectively). However,
no increase in mRNA expression level was seen for IL-18 and
IFNc.
Gene expression of Salmonella Typhimurium is affected
by exposure to 0.250 mg/mL of DON
In the stationary phase cultures of Salmonella Typhimurium,
exposure to 0.250 mg/mL of DON did not affect the gene
expression level of any gene tested in the microarray analysis.
In the logarithmic culture, 159 genes were significantly (p,0.05)
up-or downregulated $1.5-fold by exposure to 0.250 mg/mL of
DON (Table S1). A general reduction in expression of genes
involved in energy production as well as an increased expression of
emrAB multidrug efflux systems was seen. Six genes known to play
a role in the pathogenesis of a Salmonella infection were affected by
exposure to 0.250 mg/mL of DON. Three Salmonella Pathogenicity
Island-3 (SPI-3) genes were either upregulated (marT and fidL) or
downregulated (cigR), as well as the gene encoding for the SipA
Figure 2. The invasiveness of Salmonella Typhimurium in IPEC-
J2 cells after exposure to different concentrations of DON. The
number of invaded bacteria in actively dividing 1-day-old (A) or
differentiated 21-days-old (B) IPEC-J2 cells exposed to different
concentrations of DON is shown. The 1-day-old cells were exposed
either to non-cytotoxic concentrations of DON up to 0.1 mg/mL, and to
0.25 mg/mL of DON. The 21-days-old IPEC-J2 cells were exposed to non-
cytotoxic concentrations of DON up to 1 mg/mL. The results show a
representative of three independent experiments conducted in
triplicate+standard deviation. * refers to a significantly higher invasive-
ness compared to unexposed control cells (p,0.05).
doi:10.1371/journal.pone.0023871.g002
Figure 3. Impact of DON on transepithelial passage of
Salmonella Typhimurium. IPEC-J2 cells seeded onto inserts until
differentiation were either exposed to blank medium or treated with
different concentrations of DON (0.1; 0.25, 0.5; 0.75 or 1 mg/mL) for
24 h, prior to measuring the transepithelial passage of Salmonella
Typhimurium. The results show the means of four independent
experiments conducted in triplicate with their standard error of the
mean. * refers to a significantly higher translocation of the bacteria
compared to the unexposed control cells (p,0.05).
doi:10.1371/journal.pone.0023871.g003
DON Potentiates Inflammation by Salmonella
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protein and fliD and flgL, two genes encoding for hook-associate
proteins, which were downregulated.
Discussion
Both DON and salmonellosis are worldwide emerging issues
posing a threat for both animal and human health. To the best of
our knowledge this is the first time that the combined effect of
DON and an enteropathogenic pathogen such as Salmonella
Typhimurium in vivo is demonstrated.
A porcine gut loop model was used to determine whether co-
exposure to a physiologically relevant concentration of DON
could potentiate the early intestinal immune response induced by
Salmonella Typhimurium infection in the intestine. The choice for
administering 1 mg/mL of DON was based mainly on the
Commission Recommendation 2006/576/EC setting down
0.9 mg/g of DON in complementary and complete feeding stuff
for pigs as guidance value [45]. Also DON concentrations in
human intestine are estimated between 0.160 mg/mL and 2 mg/
mL depending on the contamination level of the food [17].
Moreover, 1 mg/mL was found non-cytotoxic to differentiated
IPEC-J2 cells. Undifferentiated proliferating IPEC-J2 cells are
more susceptible for the toxic effects of DON compared to highly
differentiated cells, as shown by the cytotoxicity assay. These
results correspond with the literature describing DON to be less
cytotoxic for differentiated Caco-2 cells compared to dividing cells.
No cytotoxicity was observed after 24 h exposure in differentiated
cells whereas IC10 values in the range 0.9–1.2 mM (0.260–
0.356 mg/mL) were measured for dividing cells [46].
The results presented in this study provide evidence that DON
at low but relevant intestinal concentrations enhances the
intestinal inflammatory response to Salmonella Typhimurium. This
is indicated by a significantly higher expression of IL-12 and
TNFa (p,0.05) and a clear potentiation of the expression of IL-
1b, IL-8, MCP-1 and IL-6 in loops co-exposed to 1 mg/mL of
DON and Salmonella Typhimurium.
The enhanced intestinal inflammation may be due to a
stimulation of Salmonella Typhimurium invasion in and transloca-
tion over the intestinal epithelium, as indicated by the results of the
assays performed on both dividing and differentiated IPEC-J2
cells. It has indeed been suggested that bacterial invasion
stimulates the innate pathways of inflammation by recognition of
Figure 4. Fold change in cytokine gene expression level of the porcine ileum relative to control loops. Ileal loops were exposed to 1 mg/
mL DON, Salmonella Typhimurium or 1 mg/mL DON+Salmonella Typhimurium respectively. The intestinal mRNA expression levels of the cytokines (IL-
1b, IL-6, IL-12, IL-18, IFNc and TNFa) and chemokines (IL-8 and MCP-1) 6 hours post administration was examined. Data represent the normalized
target gene amount relative to control which is considered 1. Data were presented as means+standard error of the mean for a total of 6 loops per test
condition. Bars marked with different letters indicate significantly different responses (p,0.05).
doi:10.1371/journal.pone.0023871.g004
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the pathogen-associated molecular patterns of Salmonella Typhi-
murium by TLRs present on epithelial cells and monocytes
resulting in the production of several cytokines such as IL-8 [47].
Microarray analysis on the Salmonella Typhimurium gene
expression revealed that exposure to DON only changed the gene
expression in logarithmic phase culture of Salmonella Typhimurium
and six genes of possible importance in the pathogenesis of a
Salmonella infection were affected. The marT gene, a non essential
gene for virulence, encodes for a regulatory protein and could be
involved in other aspects of pathogenesis, such as chronic infection
and host specificity [48]. The fidl and cigR gene products do not
exhibit sequence similarity to proteins with known functions in the
sequence database [48]. The genes fliD and flgL encode for
proteins involved in flagellar biosyntheses [49] and the effector
protein SipA has been shown to modulate actin dynamics in order
to promote Salmonella entry into epithelial cells [50]. The general
reduction in expression of genes involved in energy production
indicates a possible toxic effect of DON on Salmonella. The
increased expression of emrAB multidrug efflux systems suggests
that these could be involved in the removal of DON out of the
bacterium. No changes in gene expression were seen in the
stationary phase culture of Salmonella Typhimurium exposed to
DON, indicating that the Salmonella virulence was not enhanced by
DON. Since none of these bacterial gene expression alterations
seem to offer a clear explanation for the increased invasion and
translocation of Salmonella Typhimurium and the subsequent
potentiated inflammatory response seen after coexposure to
DON, we can thus conclude that the action of DON is more
likely to occur on the epithelial cells than on Salmonella. This
enhanced intestinal inflammation may be of importance for
patients genetically predisposed for IBD since both DON and
Salmonella are mentioned as factors of potential etiological
importance in the development of this chronic intestinal disorder
[25,30,31].
The enhanced susceptibility of intestinal epithelial cells to
Salmonella invasion and translocation is in accordance with our
previous findings that concentrations of DON as low as 0.025 mg/
mL enhance the uptake of Salmonella Typhimurium in porcine
macrophages associated with ERK1/2 induced cytoskeletal
reorganization [51]. Results of our present and previous studies
thus indicate that DON may influence both the intestinal and
systemic phase of a Salmonella Typhimurium infection, leading to
increased host susceptibility to this pathogen.
In pigs, intake of DON contaminated feed might result in a
higher infection level in the herd and consequently a higher public
health risk for salmonellosis from the consumption of contami-
nated pork meat.
In conclusion, our results indicate that the intake of DON
contaminated food or feed at realistic contamination levels and
after short-term exposure, could render the intestinal epithelium
more susceptible for invasive food pathogens such as Salmonella
Typhimurium with a subsequent amplification of the inflamma-
tory processes in the gut. Considering the frequent occurrence of
DON in cereal-based foods and feeds worldwide, the importance
of these findings should not be underestimated.
Supporting Information
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